MiR-27a inhibits the growth and metastasis of multiple myeloma through regulating Th17/Treg balance
PLOS ONE · 2024
DOI: 10.1371/journal.pone.0311419 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS ONE, 2024. Verfasst von Weiguo Lu und 5 weiteren Autor:innen. Beteiligte Einrichtung: The Third Clinical Medical College, Guangzhou University of Chinese Medicine, Guangzhou, Guangdong, China. Hauptthemen laut MEDLINE: MicroRNAs, Multiple Myeloma, Th17 Cells, T-Lymphocytes, Regulatory. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Traditional Chinese Medicine Bureau of Guangdong Province, Guangdong Medical Research Foundation.
Abstract (Originalsprache)
Background
The imbalance between T helper 17 (Th17) and T regulatory (Treg) cells plays a key role in the progression of multiple myeloma (MM).
Methods
The gene expression profiles of MM were acquired and examined from the Gene Expression Omnibus (GEO) database (GSE72213). Our research involved experimental investigations conducted using the MOPC-MM mouse model. Dysregulation of Treg and Th17 cells was evaluated through flow cytometry, while the levels of inflammatory factors were measured using the enzyme-linked immunosorbent assay. Cell proliferation was gauged using the Cell Counting Kit-8 assay, and cell apoptosis was quantified via flow cytometry. Cell metastasis capabilities were determined by conducting transwell assays. To confirm the relationship between miR-27a and PI3K, a dual-luciferase reporter assay was employed. Finally, proteins associated with the PI3K/AKT/mTOR signaling pathway were assessed using western blotting.
Results
MiR-27a exhibited reduced expression levels in MM. Moreover, it exerted control over the equilibrium of Th17 and Treg cells while reducing the expression of inflammatory mediators such as TGF-β1 and IL-10 in an in vivo setting. Elevated miR-27a levels led to the inhibition of cell viability, colony formation capacity, migratory and invasive traits in an in vitro context. The PI3K/AKT/mTOR signaling pathway was identified as a direct target of miR-27a and could reverse the effects induced by miR-27a in MM cells. Notably, PI3K was directly targeted by miR-27a.
Conclusions
Our study revealed that miR-27a inhibited MM evolution by regulating the Th17/Treg balance. Inhibition of the PI3K/AKT/mTOR signaling pathway by miR-27a may play a potential mechanistic role.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- The Third Clinical Medical College, Guangzhou University of Chinese Medicine, Guangzhou, Guangdong, China.
- The First Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, China.
- Guangdong Clinical Research Academy of Chinese Medicine, Guangzhou, China.
- Guangzhou University of Chinese Medicine, Guangzhou, China.
ORCID-Profile: Mingfeng Xiao
Förderung
- Traditional Chinese Medicine Bureau of Guangdong Province
- Guangdong Medical Research Foundation
Zitieren
APA
Lu, W., Huang, H., Xu, Z., Xu, S., Zhao, K., & Xiao, M. (2024). MiR-27a inhibits the growth and metastasis of multiple myeloma through regulating Th17/Treg balance. PLOS ONE. https://doi.org/10.1371/journal.pone.0311419
Vancouver
Lu W, Huang H, Xu Z, Xu S, Zhao K, Xiao M. MiR-27a inhibits the growth and metastasis of multiple myeloma through regulating Th17/Treg balance. PLOS ONE. 2024. doi:10.1371/journal.pone.0311419
BibTeX
@article{Lu2024,
author = {Lu, Weiguo and Huang, Hui and Xu, Zhanjie and Xu, Shumin and Zhao, Kewei and Xiao, Mingfeng},
title = {MiR-27a inhibits the growth and metastasis of multiple myeloma through regulating Th17/Treg balance},
journal = {PLOS ONE},
year = {2024},
doi = {10.1371/journal.pone.0311419}
}
EUVIMED